ArticleHypertension research : official journal of the Japanese Society of Hypertension2026

Reduction of interstitial fluid retention by combination therapy with dapagliflozin, an SGLT2 inhibitor, and conventional diuretics: comment on a post-hoc analysis of the DAPA-BODY trial.

Takuya TomaruPubMed ↗Publisher ↗

No numbers read from the abstract.